Prenetics Global (PRE) Competitors

$15.92 +0.45 (+2.91%)

Closing price 04:00 PM Eastern

Extended Trading

$15.86 -0.06 (-0.41%)

As of 04:10 PM Eastern

PRE vs. EYPT, ALNT, TRNS, FEIM, and CTKB

Should you buy Prenetics Global stock or one of its competitors? MarketBeat compares Prenetics Global with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Prenetics Global include Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Transcat (TRNS), Frequency Electronics (FEIM), and Cytek Biosciences (CTKB). These companies are all part of the "measuring and control equipment" industry.

How does Prenetics Global compare to Eyepoint Pharmaceuticals?

Prenetics Global (NASDAQ:PRE) and Eyepoint Pharmaceuticals (NASDAQ:EYPT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

Prenetics Global has a net margin of -61.33% compared to Eyepoint Pharmaceuticals' net margin of -3,566.63%. Prenetics Global's return on equity of -19.61% beat Eyepoint Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-61.33%	-19.61%	-15.33%
Eyepoint Pharmaceuticals	-3,566.63%	-110.54%	-90.15%

Prenetics Global has higher revenue and earnings than Eyepoint Pharmaceuticals. Prenetics Global is trading at a lower price-to-earnings ratio than Eyepoint Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$92.39M	2.91	-$37.71M	-$4.02	N/A
Eyepoint Pharmaceuticals	$31.37M	34.16	-$231.96M	-$3.50	N/A

Prenetics Global has a beta of 0.15, indicating that its share price is 85% less volatile than the broader market. Comparatively, Eyepoint Pharmaceuticals has a beta of 1.76, indicating that its share price is 76% more volatile than the broader market.

Prenetics Global presently has a consensus price target of $32.33, indicating a potential upside of 103.10%. Eyepoint Pharmaceuticals has a consensus price target of $31.80, indicating a potential upside of 148.83%. Given Eyepoint Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Eyepoint Pharmaceuticals is more favorable than Prenetics Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Eyepoint Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	3.00

25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 99.4% of Eyepoint Pharmaceuticals shares are held by institutional investors. 7.8% of Prenetics Global shares are held by company insiders. Comparatively, 4.5% of Eyepoint Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Prenetics Global and Prenetics Global both had 2 articles in the media. Eyepoint Pharmaceuticals' average media sentiment score of 0.10 beat Prenetics Global's score of 0.07 indicating that Eyepoint Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prenetics Global	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Eyepoint Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Eyepoint Pharmaceuticals beats Prenetics Global on 10 of the 16 factors compared between the two stocks.

How does Prenetics Global compare to Allient?

Allient (NASDAQ:ALNT) and Prenetics Global (NASDAQ:PRE) are both small-cap measuring and control equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability.

Allient has higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allient	$554.48M	1.93	$22.03M	$1.43	43.94
Prenetics Global	$92.39M	2.91	-$37.71M	-$4.02	N/A

Allient has a beta of 1.65, indicating that its share price is 65% more volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.15, indicating that its share price is 85% less volatile than the broader market.

61.6% of Allient shares are held by institutional investors. Comparatively, 25.0% of Prenetics Global shares are held by institutional investors. 15.0% of Allient shares are held by company insiders. Comparatively, 7.8% of Prenetics Global shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Allient currently has a consensus price target of $72.25, indicating a potential upside of 14.97%. Prenetics Global has a consensus price target of $32.33, indicating a potential upside of 103.10%. Given Prenetics Global's higher possible upside, analysts plainly believe Prenetics Global is more favorable than Allient.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allient	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Allient had 1 more articles in the media than Prenetics Global. MarketBeat recorded 3 mentions for Allient and 2 mentions for Prenetics Global. Allient's average media sentiment score of 0.27 beat Prenetics Global's score of 0.07 indicating that Allient is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Allient	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Prenetics Global	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Allient has a net margin of 4.25% compared to Prenetics Global's net margin of -61.33%. Allient's return on equity of 12.47% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allient	4.25%	12.47%	6.37%
Prenetics Global	-61.33%	-19.61%	-15.33%

Summary

Allient beats Prenetics Global on 12 of the 14 factors compared between the two stocks.

How does Prenetics Global compare to Transcat?

Prenetics Global (NASDAQ:PRE) and Transcat (NASDAQ:TRNS) are both small-cap measuring and control equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Transcat has a net margin of 2.47% compared to Prenetics Global's net margin of -61.33%. Transcat's return on equity of 6.15% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-61.33%	-19.61%	-15.33%
Transcat	2.47%	6.15%	4.15%

Transcat has higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$92.39M	2.91	-$37.71M	-$4.02	N/A
Transcat	$278.42M	2.37	$14.52M	$0.85	83.29

Prenetics Global has a beta of 0.15, meaning that its stock price is 85% less volatile than the broader market. Comparatively, Transcat has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market.

Prenetics Global presently has a consensus price target of $32.33, suggesting a potential upside of 103.10%. Transcat has a consensus price target of $105.33, suggesting a potential upside of 48.78%. Given Prenetics Global's higher probable upside, equities analysts plainly believe Prenetics Global is more favorable than Transcat.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Transcat	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

25.0% of Prenetics Global shares are owned by institutional investors. Comparatively, 98.3% of Transcat shares are owned by institutional investors. 7.8% of Prenetics Global shares are owned by company insiders. Comparatively, 2.8% of Transcat shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Prenetics Global and Prenetics Global both had 2 articles in the media. Prenetics Global's average media sentiment score of 0.07 beat Transcat's score of 0.00 indicating that Prenetics Global is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prenetics Global	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Transcat	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Transcat beats Prenetics Global on 11 of the 16 factors compared between the two stocks.

How does Prenetics Global compare to Frequency Electronics?

Prenetics Global (NASDAQ:PRE) and Frequency Electronics (NASDAQ:FEIM) are both small-cap measuring and control equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, risk and profitability.

Prenetics Global currently has a consensus target price of $32.33, suggesting a potential upside of 103.10%. Frequency Electronics has a consensus target price of $43.67, suggesting a potential downside of 27.09%. Given Prenetics Global's higher probable upside, equities analysts plainly believe Prenetics Global is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

Frequency Electronics has a net margin of 10.78% compared to Prenetics Global's net margin of -61.33%. Frequency Electronics' return on equity of 12.69% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-61.33%	-19.61%	-15.33%
Frequency Electronics	10.78%	12.69%	7.84%

Prenetics Global has a beta of 0.15, meaning that its share price is 85% less volatile than the broader market. Comparatively, Frequency Electronics has a beta of 0.53, meaning that its share price is 47% less volatile than the broader market.

25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are held by institutional investors. 7.8% of Prenetics Global shares are held by company insiders. Comparatively, 28.0% of Frequency Electronics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Frequency Electronics has lower revenue, but higher earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$92.39M	2.91	-$37.71M	-$4.02	N/A
Frequency Electronics	$69.81M	8.44	$23.69M	$0.75	79.85

In the previous week, Frequency Electronics had 2 more articles in the media than Prenetics Global. MarketBeat recorded 4 mentions for Frequency Electronics and 2 mentions for Prenetics Global. Frequency Electronics' average media sentiment score of 0.13 beat Prenetics Global's score of 0.07 indicating that Frequency Electronics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prenetics Global	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Frequency Electronics	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Frequency Electronics beats Prenetics Global on 14 of the 17 factors compared between the two stocks.

How does Prenetics Global compare to Cytek Biosciences?

Cytek Biosciences (NASDAQ:CTKB) and Prenetics Global (NASDAQ:PRE) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, media sentiment, valuation and risk.

Cytek Biosciences has a net margin of -36.25% compared to Prenetics Global's net margin of -61.33%. Cytek Biosciences' return on equity of -10.07% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytek Biosciences	-36.25%	-10.07%	-7.56%
Prenetics Global	-61.33%	-19.61%	-15.33%

Cytek Biosciences currently has a consensus target price of $5.69, suggesting a potential upside of 43.62%. Prenetics Global has a consensus target price of $32.33, suggesting a potential upside of 103.10%. Given Prenetics Global's stronger consensus rating and higher possible upside, analysts plainly believe Prenetics Global is more favorable than Cytek Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytek Biosciences	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Prenetics Global had 1 more articles in the media than Cytek Biosciences. MarketBeat recorded 2 mentions for Prenetics Global and 1 mentions for Cytek Biosciences. Prenetics Global's average media sentiment score of 0.07 beat Cytek Biosciences' score of 0.00 indicating that Prenetics Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cytek Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Prenetics Global	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

69.5% of Cytek Biosciences shares are owned by institutional investors. Comparatively, 25.0% of Prenetics Global shares are owned by institutional investors. 10.4% of Cytek Biosciences shares are owned by insiders. Comparatively, 7.8% of Prenetics Global shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Cytek Biosciences has a beta of 1.22, meaning that its share price is 22% more volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.15, meaning that its share price is 85% less volatile than the broader market.

Prenetics Global has lower revenue, but higher earnings than Cytek Biosciences. Cytek Biosciences is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytek Biosciences	$201.49M	2.54	-$66.54M	-$0.57	N/A
Prenetics Global	$92.39M	2.91	-$37.71M	-$4.02	N/A

Summary

Cytek Biosciences beats Prenetics Global on 8 of the 15 factors compared between the two stocks.

Get Prenetics Global News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRE vs. The Competition

Export

Metric	Prenetics Global	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$268.57M	$3.36B	$6.34B	$12.28B
Dividend Yield	N/A	2.32%	2.80%	5.36%
P/E Ratio	-3.96	19.02	20.92	25.48
Price / Sales	2.91	278.81	521.15	73.33
Price / Cash	N/A	125.35	43.18	55.00
Price / Book	1.72	6.90	9.98	7.01
Net Income	-$37.71M	$24.23M	$3.55B	$335.16M
7 Day Performance	-9.49%	0.65%	0.40%	-0.30%
1 Month Performance	-11.46%	-0.55%	-0.04%	1.14%
1 Year Performance	96.79%	63.42%	34.95%	34.69%

Prenetics Global Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRE Prenetics Global	2.3078 of 5 stars	$15.92 +2.9%	$32.33 +103.1%	+111.9%	$268.57M	$92.39M	N/A	1
EYPT Eyepoint Pharmaceuticals	2.7145 of 5 stars	$13.62 -2.6%	$31.80 +133.5%	+101.3%	$1.17B	$7.61M	N/A	120
ALNT Allient	3.8137 of 5 stars	$62.97 -3.8%	$72.25 +14.7%	+99.0%	$1.11B	$560.59M	44.04	2,478
TRNS Transcat	2.4103 of 5 stars	$76.06 -0.6%	$105.33 +38.5%	-28.1%	$714.01M	$278.42M	89.48	1,245	Positive News Upcoming Earnings
FEIM Frequency Electronics	1.4031 of 5 stars	$60.30 -5.9%	$43.67 -27.6%	+232.6%	$630.97M	$69.81M	80.40	200

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PRE) was last updated on 5/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Prenetics Global (PRE) Competitors

PRE vs. EYPT, ALNT, TRNS, FEIM, and CTKB

How does Prenetics Global compare to Eyepoint Pharmaceuticals?

Summary

How does Prenetics Global compare to Allient?

Summary

How does Prenetics Global compare to Transcat?

Summary

How does Prenetics Global compare to Frequency Electronics?

Summary

How does Prenetics Global compare to Cytek Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRE vs. The Competition

Prenetics Global Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Prenetics Global (PRE) Competitors

PRE vs. EYPT, ALNT, TRNS, FEIM, and CTKB

How does Prenetics Global compare to Eyepoint Pharmaceuticals?

Is PRE or EYPT more profitable?

Which has better valuation & earnings, PRE or EYPT?

Which has more volatility and risk, PRE or EYPT?

Do analysts rate PRE or EYPT?

Do institutionals and insiders believe in PRE or EYPT?

Does the media refer more to PRE or EYPT?

Summary

How does Prenetics Global compare to Allient?

Which has preferable valuation and earnings, ALNT or PRE?

Which has more volatility and risk, ALNT or PRE?

Do insiders & institutionals hold more shares of ALNT or PRE?

Do analysts prefer ALNT or PRE?

Does the media prefer ALNT or PRE?

Is ALNT or PRE more profitable?

Summary

How does Prenetics Global compare to Transcat?

Is PRE or TRNS more profitable?

Which has stronger valuation & earnings, PRE or TRNS?

Which has more risk and volatility, PRE or TRNS?

Do analysts prefer PRE or TRNS?

Do institutionals & insiders hold more shares of PRE or TRNS?

Does the media refer more to PRE or TRNS?

Summary

How does Prenetics Global compare to Frequency Electronics?

Do analysts recommend PRE or FEIM?

Is PRE or FEIM more profitable?

Which has more volatility & risk, PRE or FEIM?

Do institutionals and insiders have more ownership in PRE or FEIM?

Which has stronger valuation and earnings, PRE or FEIM?

Does the media favor PRE or FEIM?

Summary

How does Prenetics Global compare to Cytek Biosciences?

Is CTKB or PRE more profitable?

Do analysts rate CTKB or PRE?

Does the media refer more to CTKB or PRE?

Do insiders & institutionals hold more shares of CTKB or PRE?

Which has more risk and volatility, CTKB or PRE?

Which has preferable earnings & valuation, CTKB or PRE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRE vs. The Competition

Prenetics Global Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools